PT98565A - Um processo de producao de uma composicao para o tratamento da infeccao por hsv - Google Patents

Um processo de producao de uma composicao para o tratamento da infeccao por hsv

Info

Publication number
PT98565A
PT98565A PT98565A PT9856591A PT98565A PT 98565 A PT98565 A PT 98565A PT 98565 A PT98565 A PT 98565A PT 9856591 A PT9856591 A PT 9856591A PT 98565 A PT98565 A PT 98565A
Authority
PT
Portugal
Prior art keywords
treatment
production
hsv
compositions
composition
Prior art date
Application number
PT98565A
Other languages
English (en)
Other versions
PT98565B (pt
Inventor
Rae Lyn Burke
Rose E Sekulovich
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of PT98565A publication Critical patent/PT98565A/pt
Publication of PT98565B publication Critical patent/PT98565B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98565A 1990-08-02 1991-08-02 Um processo de producao de uma composicao para o tratamento da infeccao por hsv PT98565B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56152890A 1990-08-02 1990-08-02

Publications (2)

Publication Number Publication Date
PT98565A true PT98565A (pt) 1992-06-30
PT98565B PT98565B (pt) 1999-01-29

Family

ID=24242345

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98565A PT98565B (pt) 1990-08-02 1991-08-02 Um processo de producao de uma composicao para o tratamento da infeccao por hsv

Country Status (12)

Country Link
US (2) US5714152A (pt)
EP (1) EP0541692B1 (pt)
JP (3) JP3005292B2 (pt)
AT (1) ATE179614T1 (pt)
CA (1) CA2088600C (pt)
DE (1) DE69131200T2 (pt)
DK (1) DK0541692T3 (pt)
ES (1) ES2134197T3 (pt)
GR (1) GR3030834T3 (pt)
IE (1) IE912744A1 (pt)
PT (1) PT98565B (pt)
WO (1) WO1992002251A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
GB9119940D0 (en) * 1991-09-18 1991-10-30 Hare Peter F J O Polypeptide inhibitor of viral replication
US5965354A (en) * 1995-07-28 1999-10-12 Chiron Corporation Herpes simplex virus diagnostics
US5980912A (en) * 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
CA2291010A1 (en) * 1997-06-02 1998-12-10 Chiron Corporation Herpes simplex virus vp22 vaccines and methods of use
US6087166A (en) 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
PL343429A1 (en) * 1998-03-09 2001-08-13 Smithkline Beecham Biolog Combined vaccine compositions
EP1102790B1 (en) 1998-08-07 2014-05-07 University of Washington Immunological Herpes Simplex Virus antigens and methods for use thereof
US6824292B2 (en) * 1999-01-06 2004-11-30 Armament Systems And Procedures, Inc. LED flashlight with clip opposite LED
US6569616B1 (en) * 1999-07-29 2003-05-27 Wisconsin Alumni Research Foundation Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate
DE60031874D1 (de) 1999-09-30 2006-12-28 Univ Washington Immunologisch relevante antigene aus herpes simplexvirus
EP1420821B8 (en) 2001-07-31 2011-02-02 University of Washington Immunologically significant herpes simplex virus antigens and methods for using same
KR100420501B1 (ko) * 2001-09-26 2004-03-02 한국지질자원연구원 벤토나이트로부터 몬모릴로나이트 광물의 분리·회수 방법
US20040258716A1 (en) * 2002-06-17 2004-12-23 Shen Gao Ibuprofen suspension
EP2289547B1 (en) 2003-09-12 2015-12-16 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US8460674B2 (en) 2009-02-07 2013-06-11 University Of Washington HSV-1 epitopes and methods for using same
WO2010115172A2 (en) 2009-04-03 2010-10-07 University Of Washington Antigenic peptide of hsv-2 and methods for using same
NZ597182A (en) * 2009-05-22 2014-07-25 Genocea Biosciences Inc Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
AU2012340712B2 (en) 2011-11-23 2017-09-14 Genocea Biosciences, Inc. Nucleic acid vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
WO2018064232A1 (en) 2016-09-28 2018-04-05 Genocea Biosciences, Inc. Methods and compositions for treating herpes
US10745931B1 (en) 2019-08-14 2020-08-18 Premises Innovations Llc Self-rightening post system

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1678783A (en) * 1982-07-20 1984-01-26 Molecular Genetics, Inc. Production of herpes simplex viral proteins
US4818694A (en) * 1982-07-20 1989-04-04 American Cyanamid Company Production of herpes simplex viral protein
US4891315A (en) * 1982-10-25 1990-01-02 American Cyanamid Company Production of herpes simplex viral porteins
DK305784A (da) * 1983-06-23 1984-12-24 Stanley Person Ikke-glycosyleret aminosyrekaede af glycoprotein b fra herpes virus type 1 og 2
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US4642333A (en) * 1983-09-16 1987-02-10 Stanley Person Immunologically reactive non-glycosylated amino acid chains of glycoprotein B of herpes virus types 1 and 2
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
EP0628633B1 (en) * 1984-04-06 2003-01-08 Chiron Corporation Recombinant herpes simplex gB-gD vaccine
FR2563434B1 (fr) * 1984-04-25 1986-07-25 Transgene Sa Vaccin contre la rage et procede pour sa preparation
US4859587A (en) * 1984-06-04 1989-08-22 Institut Merieux Recombinant herpes simplex viruses, vaccines and methods
JPH0668B2 (ja) * 1985-08-30 1994-01-05 財団法人化学及血清療法研究所 単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
CA1337395C (en) * 1986-10-20 1995-10-24 Rae Lyn Burke Recombinant herpes simplex gb-gd vaccine
GB8917029D0 (en) * 1989-07-25 1989-09-13 Marie Curie Memorial Foundatio Polypeptide inhibitor of viral replication

Also Published As

Publication number Publication date
CA2088600C (en) 1999-11-16
IE912744A1 (en) 1992-02-12
DE69131200T2 (de) 1999-12-09
ATE179614T1 (de) 1999-05-15
JP3005292B2 (ja) 2000-01-31
JPH11308998A (ja) 1999-11-09
DK0541692T3 (da) 1999-11-01
US5795579A (en) 1998-08-18
GR3030834T3 (en) 1999-11-30
WO1992002251A1 (en) 1992-02-20
JPH06502989A (ja) 1994-04-07
ES2134197T3 (es) 1999-10-01
CA2088600A1 (en) 1992-02-03
EP0541692A1 (en) 1993-05-19
PT98565B (pt) 1999-01-29
EP0541692A4 (en) 1993-12-08
US5714152A (en) 1998-02-03
DE69131200D1 (en) 1999-06-10
EP0541692B1 (en) 1999-05-06
JP2002136297A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
PT98565A (pt) Um processo de producao de uma composicao para o tratamento da infeccao por hsv
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
BR9814473A (pt) Imunógenos anti-retrovirais, preparação e uso
AU7355387A (en) Cosmetic products based on n-hydroxybutyl-chitosans, new n-hydroxybutyl-chitosans and process for their manufacture
IL104780A0 (en) Sulfonic acid derivatives in the treatment of viral diseases
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
DE69230798T2 (de) Rekombinante immuntoxine
DE69613058T2 (de) Vorbeugung und Behandlung von topischen viralen Infektionen mit Perfluoropolyäthern oder deren Zusammensetzungen
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
ES2169037T3 (es) Conjugados polietilenglicol-hirudina, su procedimiento de preparacion y su empleo para el tratamiento de las trombosis.
DE69332111D1 (de) Darmprotozoen-Impfstoffe
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
AU4312093A (en) Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
ES2078380T3 (es) Oligofosfatos de accion antiviral.
BR9205877A (pt) Processo e composiçao para o tratamento de infecçoes por herpes.
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
BR9611033A (pt) Processos para tratar infecção por h.pylori, em um mamífero e para converter a forma coccóide de h. pylori em cultura na forma em espiral e a forma em espiral de h.pylori em cultura na forma coccóide, formulação farmaceutica e uso de um agente capaz de induzir a forma coccóide de h.pylori
ES2072431T3 (es) D-acido aspartico beta-hidroxamato para el tratamiento de infecciones virales y de tumores.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920218

FG3A Patent granted, date of granting

Effective date: 19981020

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040430